Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
7
×
national blog main
clinical trials
fda
boston blog main
national top stories
boston
boston top stories
deals
investing
san francisco blog main
covid-19
drug delivery
eli lilly
national
new york blog main
san diego blog main
san diego top stories
san francisco top stories
startups
480 biomedical
abbvie
abcellera
aimmune therapeutics
akouos
allergan
allergy
alnylam
amgen
anaphylaxis
andrew oxtoby
antibodies
arena pharmaceuticals
arsenal medical
artie suckow
astellas pharmaceuticals
biofourmis
biohaven
biovotion
What
treat
7
×
medicines
therapeutics
approved
fda
new
biologics
biotech
developing
drug
ipo
late
million
raised
raises
way
abcellera
abcellera’s
adults
advance
affects
agency
aimmune
allergan
allergy
americans
analytics
antibodies
antibody
approval
awarded
based
biofourmis
class
company
considered
coronavirus
data
date
debut
Language
unset
7
×
Current search:
treat
×
unset
×
" life sciences "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds